Monday, October 12, 2026

EUR/JPY Is 1% Up In The Last 21 Sessions

EUR/JPY Is 1% Up In The Last 21 Sessions

(VIANEWS) - EUR/JPY (EURJPY) has been up by 1.6% for the last 21 sessions. At 17:09 EST on Monday, 10 April, EUR/JPY (EURJPY) is $145.03.

EUR/JPY's yearly highs and lows, it's 9.254% up from its 52-week low and 2.245% down from its 52-week high.

Volatility

EUR/JPY's last week, last month's, and last quarter's current intraday variation average was a positive 0.05%, a negative 0.07%, and a positive 0.55%, respectively.

EUR/JPY's highest amplitude of average volatility was 0.40% (last week), 0.68% (last month), and 0.55% (last quarter), respectively.

News about

  • Usd/jpy drives to 132.50 as US employment data supports more rate hikes from fed. According to FXStreet on Monday, 10 April, "The USD/JPY pair has extended its recovery after a nominal correction to 132.50 in the Asian session amid hopes of further escalation in interest rates by the Federal Reserve (Fed). "
  • Usd/jpy price analysis: bulls eye another battle with 50-dma hurdle surrounding 133.00. According to FXStreet on Monday, 10 April, "In a case where the USD/JPY pair remains firmer past 135.20, the Year-To-Date (YTD) high of 137.91 should lure the bulls before highlighting the 140.00 psychological magnet.", "It's worth noting, however, that the 50-DMA hurdle, around 133.20, appears a short-term key challenge for the USD/JPY buyers to pass if they wish to keep the reins."
  • Usd/jpy trims a part of intraday gains to four-day high, holds above 132.00 mark. According to FXStreet on Monday, 10 April, "The USD/JPY pair scales higher for the third successive day on Monday and touched a four-day high, around the 132.80 region, albeit lacks follow-through. ", "This week's US economic docket also features the release of the latest consumer inflation figures and monthly retail sales data, which will play a key role in influencing the near-term USD price dynamics and determining the next leg of a directional move for the USD/JPY pair."
  • Usd/jpy forecast: buying on dips against yen - 10 April 2023. According to DailyForex on Monday, 10 April, "The USD/JPY pair has been hovering around the ¥131 level for some time now, as investors continue to ponder the Bank of Japan's yield curve control measures.", "The USD/JPY pair may experience some downside pressure, with the 50-day exponential moving average acting as the support level. "
  • Usd/jpy jumps closer to 100 DMA barrier near mid-133.00s amid broad-based USD strength. According to FXStreet on Monday, 10 April, "This, in turn, continues to push the USD higher, which, along with dovish-sounding remarks by the new Bank of Japan (BoJ) Governor Kazuo Ueda, prompt aggressive short-covering around the USD/JPY pair.", "This, in turn, weighs heavily on the Japanese Yen (JPY) and provides an additional boost to the USD/JPY pair. "

More news about EUR/JPY (EURJPY).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com